Descrizione
Safety and tolerability data from the randomized trial of FOS in infant constipation. The findings evaluate adverse events and acceptability of fructooligosaccharide supplementation in this young patient population.
Figure 4
ChartSource Paper
Randomized, Double-Blind, Placebo-Controlled Parallel Clinical Trial Assessing the Effect of Fructooligosaccharides in Infants with Constipation.Cite This Figure
![Figure 4: Safety and tolerability data from the randomized trial of FOS in infant constipation. The findings evaluate adverse events and acceptability of fructooligosaccharide supplementation in this young patient population.]() > Source: Daniela da Silva Souza et al. "Randomized, Double-Blind, Placebo-Controlled Parallel Clinical Trial Assessing t." *Nutrients*, 2018. PMID: [30388751](https://pubmed.ncbi.nlm.nih.gov/30388751/)
<figure> <img src="" alt="Safety and tolerability data from the randomized trial of FOS in infant constipation. The findings evaluate adverse events and acceptability of fructooligosaccharide supplementation in this young patient population." /> <figcaption>Figure 4. Safety and tolerability data from the randomized trial of FOS in infant constipation. The findings evaluate adverse events and acceptability of fructooligosaccharide supplementation in this young patient population.<br> Source: Daniela da Silva Souza et al. "Randomized, Double-Blind, Placebo-Controlled Parallel Clinical Trial Assessing t." <em>Nutrients</em>, 2018. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/30388751/">30388751</a></figcaption> </figure>